BCR::ABL1 Kinase Domain Variant (Mutation) Status
EPTIS factsheet 146052 | Last revision 2024-04-19 | URL: https://www.eptis.bam.de/pts146052 https://www.eptis.bam.de/pts146052
| PT provider | ||||||||||
| PT provider | UK NEQAS for Leucocyte Immunophenotyping UK NEQAS for Leucocyte Immunophenotyping | |||||||||
| Based in | United Kingdom | |||||||||
| Language(s) | English | |||||||||
| Remarks | Please refer to our website for further information: www.ukneqasli.co.uk Qualitative programme, quantitative data submission optional. Educational low level samples and clinical scenarios may be included. Previously known as BCR-ABL1 Kinase Domain Variant (Mutation) Status | |||||||||
| Keywords | ||||||||||
| Product groups | ||||||||||
| Testing fields |
Biology
Medical analysis |
|||||||||
| Technical details | ||||||||||
|
||||||||||
| Aims of the PT scheme | ||||||||||
| Target group of participants | Participation is open to both UK and international laboratories. | |||||||||
| Linked to specific legislation / standards | ISO 17043:2010 ISO 15189:2012 | |||||||||
| Additional, subsidiary aims | validation of testing methods | |||||||||
| Number of participants | 85 | |||||||||
| Accredited or otherwise reviewed by a 3rd party |
Accredited by UKAS on the basis of ISO 17043 |
|||||||||
| Operation is commissioned / requested by | ||||||||||
| Fees and frequency | ||||||||||
| Participation fee | Please contact UK NEQAS LI for details | |||||||||
| Regularly operated | Yes (3 per annum (each send-out includes 2 samples)) | |||||||||
| Year of first operation | 2013 | |||||||||
| Contact details of the PT provider | ||||||||||
| Provider | Contact person | |||||||||
|
UK NEQAS for Leucocyte Immunophenotyping
4th Floor, Pegasus House, 463a Glossop Road S10 2QD Sheffield United Kingdom Phone: +44 (0) 114 2673600 Fax: Web: http://www.ukneqasli.co.uk http://www.ukneqasli.co.uk |
Mr Stuart Scott
Phone: +44 (0) 114 2673600 Fax: Email: admin@ukneqasli.co.uk admin@ukneqasli.co.uk |
|||||||||